Cargando…

Comparison of BISAP, Ranson, MCTSI, and APACHE II in Predicting Severity and Prognoses of Hyperlipidemic Acute Pancreatitis in Chinese Patients

In recent years, with the developing of living standard, hyperlipidemia becomes the second major reason of acute pancreatitis. It is important to predict the severity and prognosis at early stage of hyperlipidemic acute pancreatitis (HLAP). We compared the BISAP, Ranson, MCTSI, and APACHE II scoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lixin, Liu, Jing, Xing, Yun, Du, Lichuan, Chen, Jing, Liu, Xin, Hao, Jianyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110880/
https://www.ncbi.nlm.nih.gov/pubmed/27882045
http://dx.doi.org/10.1155/2016/1834256
_version_ 1782467762151489536
author Yang, Lixin
Liu, Jing
Xing, Yun
Du, Lichuan
Chen, Jing
Liu, Xin
Hao, Jianyu
author_facet Yang, Lixin
Liu, Jing
Xing, Yun
Du, Lichuan
Chen, Jing
Liu, Xin
Hao, Jianyu
author_sort Yang, Lixin
collection PubMed
description In recent years, with the developing of living standard, hyperlipidemia becomes the second major reason of acute pancreatitis. It is important to predict the severity and prognosis at early stage of hyperlipidemic acute pancreatitis (HLAP). We compared the BISAP, Ranson, MCTSI, and APACHE II scoring system in predicting MSAP and SAP, local complications, and mortality of HLAP. A total of 326 diagnosed hyperlipidemic acute pancreatitis patients from August 2006 to July 2015 were studied retrospectively. Our result showed that all four scoring systems can be used to predict the severity, local complications, and mortality of HLAP. Ranson did not have significant advantage in predicting severity and prognosis of HLAP compared to other three scoring systems. APACHE II was the best in predicting severity of HLAP, but it had shortcoming in predicting local complications. MCTSI had outstanding performance in predicting local complications, but it was poor in predicting severity and mortality. BISAP score had high accuracy in assessment of severity, local complications, and mortality of HLAP, but the accuracy still needs to be improved in the future.
format Online
Article
Text
id pubmed-5110880
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-51108802016-11-23 Comparison of BISAP, Ranson, MCTSI, and APACHE II in Predicting Severity and Prognoses of Hyperlipidemic Acute Pancreatitis in Chinese Patients Yang, Lixin Liu, Jing Xing, Yun Du, Lichuan Chen, Jing Liu, Xin Hao, Jianyu Gastroenterol Res Pract Research Article In recent years, with the developing of living standard, hyperlipidemia becomes the second major reason of acute pancreatitis. It is important to predict the severity and prognosis at early stage of hyperlipidemic acute pancreatitis (HLAP). We compared the BISAP, Ranson, MCTSI, and APACHE II scoring system in predicting MSAP and SAP, local complications, and mortality of HLAP. A total of 326 diagnosed hyperlipidemic acute pancreatitis patients from August 2006 to July 2015 were studied retrospectively. Our result showed that all four scoring systems can be used to predict the severity, local complications, and mortality of HLAP. Ranson did not have significant advantage in predicting severity and prognosis of HLAP compared to other three scoring systems. APACHE II was the best in predicting severity of HLAP, but it had shortcoming in predicting local complications. MCTSI had outstanding performance in predicting local complications, but it was poor in predicting severity and mortality. BISAP score had high accuracy in assessment of severity, local complications, and mortality of HLAP, but the accuracy still needs to be improved in the future. Hindawi Publishing Corporation 2016 2016-11-02 /pmc/articles/PMC5110880/ /pubmed/27882045 http://dx.doi.org/10.1155/2016/1834256 Text en Copyright © 2016 Lixin Yang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yang, Lixin
Liu, Jing
Xing, Yun
Du, Lichuan
Chen, Jing
Liu, Xin
Hao, Jianyu
Comparison of BISAP, Ranson, MCTSI, and APACHE II in Predicting Severity and Prognoses of Hyperlipidemic Acute Pancreatitis in Chinese Patients
title Comparison of BISAP, Ranson, MCTSI, and APACHE II in Predicting Severity and Prognoses of Hyperlipidemic Acute Pancreatitis in Chinese Patients
title_full Comparison of BISAP, Ranson, MCTSI, and APACHE II in Predicting Severity and Prognoses of Hyperlipidemic Acute Pancreatitis in Chinese Patients
title_fullStr Comparison of BISAP, Ranson, MCTSI, and APACHE II in Predicting Severity and Prognoses of Hyperlipidemic Acute Pancreatitis in Chinese Patients
title_full_unstemmed Comparison of BISAP, Ranson, MCTSI, and APACHE II in Predicting Severity and Prognoses of Hyperlipidemic Acute Pancreatitis in Chinese Patients
title_short Comparison of BISAP, Ranson, MCTSI, and APACHE II in Predicting Severity and Prognoses of Hyperlipidemic Acute Pancreatitis in Chinese Patients
title_sort comparison of bisap, ranson, mctsi, and apache ii in predicting severity and prognoses of hyperlipidemic acute pancreatitis in chinese patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110880/
https://www.ncbi.nlm.nih.gov/pubmed/27882045
http://dx.doi.org/10.1155/2016/1834256
work_keys_str_mv AT yanglixin comparisonofbisapransonmctsiandapacheiiinpredictingseverityandprognosesofhyperlipidemicacutepancreatitisinchinesepatients
AT liujing comparisonofbisapransonmctsiandapacheiiinpredictingseverityandprognosesofhyperlipidemicacutepancreatitisinchinesepatients
AT xingyun comparisonofbisapransonmctsiandapacheiiinpredictingseverityandprognosesofhyperlipidemicacutepancreatitisinchinesepatients
AT dulichuan comparisonofbisapransonmctsiandapacheiiinpredictingseverityandprognosesofhyperlipidemicacutepancreatitisinchinesepatients
AT chenjing comparisonofbisapransonmctsiandapacheiiinpredictingseverityandprognosesofhyperlipidemicacutepancreatitisinchinesepatients
AT liuxin comparisonofbisapransonmctsiandapacheiiinpredictingseverityandprognosesofhyperlipidemicacutepancreatitisinchinesepatients
AT haojianyu comparisonofbisapransonmctsiandapacheiiinpredictingseverityandprognosesofhyperlipidemicacutepancreatitisinchinesepatients